CBD and the USA Government

Correct, the Government of the United States of America holds the patent on Cannabinoids. CBD is a Cannabinoid. 
Should you open the patent page and do a ctrl + F and type in CBD you will see it is mentioned 46 times. 
YES we have done our homework. Prior to opening our store we spent 6 months researching to always come back to information provided by Health and Human Services by way of reading the patent. Please keep in mind we support our Government 100%. Please realize we are in business because we are fortunate enough to live in the USA. Thank you!  
Ground ZERO for the study of Cannabis is Israel.     
Israel and the United States Government have been working together since the early 60s.  

Watch the video below Dr. Raphael Mechoulam
The scientist... The Father of Cannabis research. GREAT MAN! 
The guy with the long hair in the video is Mary Lynn Mathre's husband. 
Mary Lynn is the mother of Cannabis. Her videos are also on this page. 

YouTube Video



Original Assignee

CBD
The Acronym for cannabidiol = CBD  
The United States Of America As Represented By 
The Department Of Health And Human Services

CBD is the acronym for cannabidiol and is 1 of over 85 Cannabinoids 

Products from this store come from Industrial HEMP oil which contains CBD


Cannabinoids as antioxidants and neuroprotectants
 

#CBD

Publication number US6630507 B1
Publication type Grant
Application number US 09/674,028
PCT number PCT/US1999/008769
Publication date Oct 7, 2003
Filing date Apr 21, 1999
Priority date Apr 21, 1998
Fee status Paid
Also published as CA2329626A14 More »
Inventors Aidan J. HampsonJulius AxelrodMaurizio Grimaldi
Original Assignee The United States Of America As Represented By The Department Of Health And Human Services
Export Citation BiBTeXEndNoteRefMan
Patent Citations (22), Non-Patent Citations (29), Referenced by (10),Classifications (16), Legal Events (4)
External Links: USPTOUSPTO AssignmentEspacenet
ABSTRACT 
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3

mary lynn mathre

Mary Lynn from Patients Out of Time


Mary Lynn from Patients Out of Time


Mary Lynn from Patients Out of Time


 www.medicalcannabis.com

Mary Lynn from Patients Out of Time


Mary Lynn from Patients Out of Time


 www.medicalcannabis.com

YouTube Video



  http://www.cbdstore.co/buy-canchew-gum

When the US Govt has the patent... Well it is all about the CBD!